Lanzon, B.; Martin-Taboada, M.; Castro-Alves, V.; Vila-Bedmar, R.; González de Pablos, I.; Duberg, D.; Gomez, P.; Rodriguez, E.; Orešič, M.; Hyötyläinen, T.;
et al. Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. Metabolites 2021, 11, 836.
https://doi.org/10.3390/metabo11120836
AMA Style
Lanzon B, Martin-Taboada M, Castro-Alves V, Vila-Bedmar R, González de Pablos I, Duberg D, Gomez P, Rodriguez E, Orešič M, Hyötyläinen T,
et al. Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. Metabolites. 2021; 11(12):836.
https://doi.org/10.3390/metabo11120836
Chicago/Turabian Style
Lanzon, Borja, Marina Martin-Taboada, Victor Castro-Alves, Rocio Vila-Bedmar, Ignacio González de Pablos, Daniel Duberg, Pilar Gomez, Elias Rodriguez, Matej Orešič, Tuulia Hyötyläinen,
and et al. 2021. "Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity" Metabolites 11, no. 12: 836.
https://doi.org/10.3390/metabo11120836
APA Style
Lanzon, B., Martin-Taboada, M., Castro-Alves, V., Vila-Bedmar, R., González de Pablos, I., Duberg, D., Gomez, P., Rodriguez, E., Orešič, M., Hyötyläinen, T., Morales, E., Ruperez, F. J., & Medina-Gomez, G.
(2021). Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. Metabolites, 11(12), 836.
https://doi.org/10.3390/metabo11120836